Skip to content

Christopher Ogden, Chief Financial Officer at CytomX Therapeutics, sold CTMX on Jun 15, 2026

Data as of Oct 27

▼ SELL$5K1,624 shares at $3.05Christopher Ogden Chief Financial OfficerCTMX CytomX Therapeutics, Inc.
Watch CTMX
Traded
Jun 15, 2026
Disclosed
Jun 17, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Christopher Ogden, Chief Financial Officer at CytomX Therapeutics, sold CTMX on Jun 15, 2026TRADEDDISCLOSED
CTMXSimilar stocks (XLV — its sector index fund), rebased to CTMX's price on the disclosure day
CTMX since disclosure
−22.0%
after the sale
Similar stocks (XLV) since disclosure
+18.9%
XLV — its sector index fund

Change in closing price from Jun 17, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on CTMX →